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Acute exacerbation of IPF has systemic
consequences with multiple organ injury,
with SRA+ and TNF-α+ cells in the systemic
circulation playing central roles in multiple
organ injury
Iwao Emura* and Hiroyuki Usuda
Abstract
Background: The pathophysiologic mechanisms underlying acute exacerbation of idiopathic pulmonary fibrosis
(IPF) are not fully understood. Few studies have examined autopsy findings in patients who have died from an
acute exacerbation of IPF. The pathologic findings in systemic organs have not been described.
Methods: We retrospectively reviewed the autopsy findings in 12 patients who had died from an acute exacerbation
of IPF and two of connective tissue disease- associated interstitial lung disease between 2005 and 2015. We recorded
demographic and clinical characteristics, autopsy findings and cytologic findings in peripheral blood.
Results: The median age at autopsy was 68 years (range 45–87 years); 11 subjects (78.5 %) were men. High-dose
corticosteroid, cyclophosphamide and oxygen therapy had been administered to all patients. Underlying lesions had
the usual interstitial pneumonia pattern; diffuse alveolar damage and contraction band necrosis were observed in all
cases. Large cells expressing scavenger receptor A (SRA+) had been observed in the systemic circulation of 11 of the 14
cases (78.6 %) before acute exacerbation, and cells expressing tumor necrosis factor-α (TNF-α+) were detected after its
diagnosis in nine (64.3 %). Both were detected in all cases at autopsy. There was neutrophil and platelet accumulation
predominantly in capillaries, and extensive capillary endothelial cells injury.
Conclusions: Our findings suggest that acute exacerbation of IPF has systemic consequences with multiple organ
injury, with SRA+ and TNF-α+ cells in the systemic circulation playing central roles in multiple organ injury.
Keywords: Acute exacerbation, Autopsy, Multiple organ injury, Peripheral blood, Scavenger receptor A, Tumor necrosis
factor-α
Background
Many patients with idiopathic pulmonary fibrosis (IPF)
may experience sudden worsening of respiratory symp-
toms [1]. This frequently occurs without an identifiable
cause, and is termed acute exacerbation of IPF [2]. Acute
exacerbations have now also been reported in patients
with connective tissue disease (CTD)-associated intersti-
tial lung disease (ILD) and other ILDs [3–5].
The pathophysiologic mechanisms underlying an acute
exacerbation are not fully understood [6]. Idiopathic
pulmonary fibrosis is defined as a specific form of inter-
stitial pneumonia limited to the lung [7]. At autopsy,
histopathologic evidence of diffuse alveolar damage
(DAD) is frequently observed in patients who have died
from an acute exacerbation of IPF [5, 8, 9]. This finding
is shared with the acute respiratory distress syndrome
(ARDS) [10] which is considered to be a systemic multi-
organ disease [11–13]. Nonetheless, the existing patho-
logic evidence base in IPF and CTD-associated ILD do
not include an assessment of the peripheral blood or
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systemic organs in patients who have died of an acute
exacerbation [5, 8, 9, 14].
We have previously reported that cells expressing
scavenger receptor A (SRA) and tumor necrosis factor-α
(TNF-α) can be identified at autopsy in the systemic
circulation of patients who had died with multiple organ
dysfunction syndrome (including those with ARDS).
Large SRA+ cells were observed only in patients who
had died of multiple organ dysfunction syndrome, while
small SRA+ cells were observed in all healthy control.
These findings suggest that large SRA+ and TNF-α+ cells
play important roles in the development of multiple
organ injury [15]. The objective of this study was to
examine systemic organs and peripheral blood collected
in patients who have died of acute exacerbation of IPF




Fourteen autopsy cases of acute exacerbation were
examined (12 of IPF, and two of CTD-associated ILD).
Patients whose immediate causes of death was consid-
ered to be severe bronchopneumonia, aspiration pneu-
monia or lung cancer were excluded from the analysis.
The presence of current infectious was evaluated using
several techniques. Sputum microbiology and blood
culture were performed in all patients, and bronchoalve-
olar lavage in 10. No specific pathogens were isolated in
sputum, bronchoalveolar lavage fluid or blood. Cyto-
megalovirus antigenemia and β-D-glucan tests were
negative in all patients.
Methods
Autopsy
Autopsy was performed 2–3 h after death. Major organs
were removed and sections were examined after staining
with hematoxylin and eosin, Gram stain, methenamine
silver-nitrate Grocott’s variation stain, and phosphotung-
stic acid hematoxylin (PTAH) stain.
Cytology
We elected to examine peripheral blood specimens
taken before and after the diagnosis of acute exacerba-
tion of IPF or CTD-associated ILD, and at autopsy, for
the presence of SRA+ and TNF-α+ cells. Stored periph-
eral blood samples (median: 2 samples before diagnosis
of acute exacerbation, range: 1–5 specimens, median: 3
specimens after diagnosis, range: 1–9 specimens), and
those obtained from the right atrium at autopsy were
collected in tubes containing EDTA (Vacutainer plastic,
EDTA 2 K, Becton Dickinson, USA). Papanicolaou-
stained smears were prepared: erythrocytes were lysed
with lysing reagent (826 mg NH4CL + 3.7 mg EDTA-
4Na + 100 mg KHCO3 in 100 ml H2O), nucleated cells
were suspended in isotonic sodium chloride solution,
and suspensions containing approximately 5 × 106 nucle-
ated cells were smeared on glass slides using Auto smear
CF-12 (Sakura Seiki, Tokyo, Japan). Cells that did not
adhere to glass slides were gently washed off with 95 %
ethanol solution. Smear preparations were fixed in 95 %




Papanicolaou-stained smears and paraffin sections were
examined using the simple stain MAX-PO method
(Nichrei Co., Tokyo, Japan) with diaminobenzidine as
the chromogen using mouse monoclonal anti-human
glycoprotein 1b (CD42b, a platelet marker, Novo Castra,
Newcastle-upon- Tyne, UK, 1:100), mouse monoclonal
anti-human keratin (AE1/AE3, an epithelial marker,
DAKO USA, Carpinteria, CA, USA, 1:150), mouse
monoclonal anti-human transmembrane glycoprotein
(CD34, an endothelial cell marker, DAKO USA, Carpin-
teria, CA, USA), mouse monoclonal anti-human TNF-α
(Abcam, Cambridge, UK, 1:100) and mouse monoclonal
anti-human SRA (CD204, a macrophage SRA marker,
1:200, Trans Genic Inc., Kumamoto, Japan) antibodies.
An antigen retrieval method using citrate buffer and
microwave heating was employed for all antibodies. As a
negative control, the primary antibody was substituted
with phosphate- buffered saline, and a positive stain was
not observed in these controls.
Diagnoses
The diagnoses of IPF and its acute exacerbation were
made according to the statements of national and inter-
national respiratory medicine societies [6, 7]. The diag-
nosis of acute exacerbation of CTD-associated ILD was
made using the same criteria as IPF. We examined the
number of necrotic cardiac myocytes in 1 cm2 PTAH
stained sections. When necrotic myocytes were observed
as a small group and the exact number could not be
counted, we described them as “many,” as shown in
Table 1. SRA+ cells in peripheral blood that were over
twice as large as monocytes were defined as large SRA+
cells. We defined alveolar tissue as injury as an absence
of alveolar epithelial cells, with peri-alveolar cytokeratin-
positive cell debris and mild edema and extravasation.
We defined capillary injury as a reduction in number or
absence of tube-like or ring-like structures. Alveolar and
capillary injuries were identified in immunohistochemi-
cal preparations stained with AE1/AE3 or CD34
antibodies. The diagnosis of multiple organ injury was
made if 2 or more organs were injured.
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Results
Patient characteristics
Three patients presented with acute respiratory symp-
toms that were diagnosed as an acute exacerbation of
IPF; they had not previously been diagnosed with a
respiratory disease. The other 11 patients developed
acute exacerbation during management of previously-
diagnosed IPF or CTD-associated ILD. Median period
from the diagnosis of IPF to acute exacerbation of
the 11 patients was 14 month (range: 2–26 months).
Two patients were acute exacerbation of CTD-
associated ILD. All patients had received corticoster-
oid therapy before the exacerbation, and high-dose
corticosteroids and cyclophosphamide after diagnosis
of acute exacerbation. All had been treated with
oxygen for 1–12 days before death. After reviewing
the pathologic findings and clinical records, we deter-
mined that chemotherapy and oxygen had not
substantially influenced the pathologic findings in any
case.
Pathologic findings in the lungs
The usual interstitial pneumonia pattern and the ex-
udative phase of DAD were observed in all cases; the
proliferative phase of DAD was observed in 12 cases
(85.7 %, Table 1).
Acute inflammatory lung injury was classified into
one of two types. The first exhibited pathologic find-
ings consistent with the exudative stage of DAD, such
as hyaline membranes, congestion, varying amounts
of extravasation and fibrin deposition, intra-alveolar
edema, neutrophils in the alveolar septal walls and air
spaces (Fig. 1a), the injury and disappearance of al-
veolar epithelial cells (Fig. 1b), and platelets accumula-
tion predominantly in the capillaries of the alveolar
septal walls (Fig. 1c). In the second type, all of the
above mentioned findings apart from hyaline mem-
branes were observed (Figs. 1d, 2a, and b).
Pathologic findings in the heart
Contraction band necrosis of varying duration was
observed in both ventricular walls (Fig. 2c). Conges-
tion and accumulation of neutrophils (Fig. 2d) and
platelets (Fig. 3a) in capillaries were observed in all
cases. Numerous tube-like or ring-like structures were
observed among cardiac myocytes in normal cardiac
tissue; however these structures were markedly re-
duced in number, and injured capillary endothelial
cells had ragged cytoplasm (Fig. 3b).
Pathologic findings on other organs
Necrosis of hepatocytes was observed in nine cases
(64.3 %), necrosis of renal tubular epithelial cells was
observed in nine cases (64.3 %) and a shallow gastric
ulcer was detected in four cases (28.6 %, Table 1).
Accumulation of neutrophils and platelets in capillar-
ies or sinusoidal capillaries were observed in injured
organs. There was no evidence of severe tissue injury
or sepsis in any case. Specific pathogens were not
observed in any organs.
Table 1 Histopathologic and cytologic findings
Age Sex AE-
D
Lung Heart Liver Kid. Sto. Large SRA+ cells TNF-α+ cells
Before AE At Death After AE At Death
1 83 M 4 DAD(E) <1 − − − ND 5 ND 1
2 82 M 26 DAD(E,P) many + + − 1 66 0 4
3 83 M 35 DAD(E,P) 2 − − − ND 12 ND 2
4 63 M 24 DAD(E,P) many + + − 2 609 1 5
5 58 F 7 DAD(E,P) many + + + 0 2 0 3
6 45 M 30 DAD(E,P) 7 + + + 1 44 4 2
7 59 F 27 DAD(E,P) many + − + 4 1015 1 7
8 73 M 20 DAD(E,P) many − − − 2 84 2 3
9 64 M 60 DAD(E,P) 47 + + + 1 413 3 2
10 68 M 16 DAD(E,P) 38 + + − 1 91 0 4
11 61 M 30 DAD(E,P) 20 + + − 1 189 2 5
12 63 F 50 DAD(E,P) 8 − − − 5 546 5 8
13 74 M 75 DAD(E,P) 31 − + − 3 72 2 1
14 87 M 7 DAD(E) many + + − 5 4 1 2
AE-D represents the duration from the diagnosis of acute exacerbation to death (days). Abbreviations: AE acute exacerbation, Kid Kidney, Sto Stomach, SRA
Scavenger receptor A, TNF Tumor necrosis factor, M Male, F Female, DAD Diffuse alveolar damage, E Exudative phase, P Proliferative phase, ND No data
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Cytological findings of PB
About 1.0 × 106 nucleated cells were smeared in one 1.2 ×
1.2 cm2 area. Only one to three large SRA+ cells and TNF-
α+ cells were observed in some of the smears prepared
from peripheral blood specimens taken before death. Large
SRA+ cells were observed in 11 cases before acute exacer-
bation was diagnosed (78.6 %, Fig. 3c). TNF-α+ cells were
detected after the diagnosis of acute exacerbation in nine
patients (64.3 %, Fig. 3d). Large SRA+ cells and TNF-α+
cells were detected in all cases at autopsy (Table 1).
Fig. 1 Acute inflammatory lung injury of types 1 (a-c) and type 2 (d). a The exudative phase of diffuse alveolar damage with a hyaline membrane
with neutrophils accumulation in alveolar septa and air spaces. b Alveolar epithelial cells absent from alveoli (arrow) and cytokeratin positive cell
debris in air spaces. c Accumulation of platelets mostly in the capillaries of the alveolar septa. d Mild congestion, edema and extravasation with
neutrophils accumulation in alveolar septa and air spaces. Scale bars: 30 μm (a-d). Immunohistochemistry for AE1/AE3 (b) and CD42b (c)
Fig. 2 Type 2 acute inflammatory lung injury (a, b) and cardiac injury (c, d). a Alveolar epithelial cells absent from alveoli (arrow) and cytokeratin
positive cell debris in air spaces. b Accumulation of platelets mostly in the capillaries of the alveolar septa. c Contraction band necrosis of a
variety of durations. d Accumulation of neutrophils mostly in capillaries. Scale bar: 30 μm (a-d). Immunohistochemistry for AE1/AE3 (a) and CD42b
(b). Phosphotungstic acid hematoxylin (c)
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Discussion
Although CTD-associated ILD and IPF are considered
to have different underlying pathogenesis, acute exacer-
bation has been reported in patients with CTD-
associated ILD and other ILDs [3–5]. We judge that the
histopathologic findings that we detected were conse-
quence of acute exacerbation, since the histopathological
findings of type 1 and 2 acute inflammatory lung injury
were different from those of diagnostic histologic find-
ings of idiopathic pulmonary fibrosis (usual interstitial
pneumonia) [16]. We were unable to detect any histo-
pathologic or cytologic differences between the 12 cases
of IPF and two cases of CTD-associated ILD in our co-
hort. We propose that the same pathophysiologic mech-
anism underpin acute exacerbation in these diseases.
We classified acute inflammatory lung injury into two
types, which had similar histopathologic and cytologic
features except for the presence of hyaline membranes.
Consequently, we judge that the same basic cellular and
pathophysiologic mechanisms underpin these two types
of injury. The earliest changes of DAD identifiable in the
lung are reportedly detectable by electron microscopy; at
the ultrastructural level, there was evidence of injury
and necrosis of type I and II pneumocytes [17, 18].
Hyaline membranes form 2–3 days after injury. There-
fore, we propose that the second type of lung injury that
we observed is the earliest stage of DAD.
We found DAD and contraction band necrosis in all
cases, necrosis of hepatocytes and renal tubular epithe-
lial cells and shallow gastric ulcers in a substantial
proportion. Cytokine abnormality were considered to
play central role in these tissue or cell injury since accu-
mulation of neutrophils and platelets in capillaries or
sinusoidal capillaries were observed in injured organs. It
is thought that IPF is a specific form of interstitial pneu-
monia limited to the lung [7]. Although our cohort was
small, our findings suggest that acute exacerbation is a
systemic disorder that causes multiple organ injury.
We detected SRA+ cells and TNF-α+ cells in the sys-
temic circulation in all cases. Neutrophils and platelets
had accumulated mainly in capillaries in the alveolar
septa and among cardiac myocytes. Capillary endothelial
cells were injured. Contraction band necrosis is associ-
ated with reperfusion injury [19]. It is widely believed
that pro-inflammatory cytokines released by macro-
phages cause neutrophils to adhere to capillaries and be-
come activated. Activated neutrophils release oxidants
and proteases that contribute to tissue damage [20, 21].
We propose that the pathophysiologic mechanisms
underlying multiple organ injury in our cases begin with
a rapid and substantial release of cytokines into the
systemic circulation by activated macrophages causing
an imbalance between pro- and anti-inflammatory medi-
ators. Neutrophils and capillary endothelial cells would
be activated by these pro-inflammatory cytokines; the
adhesion of neutrophils to capillary endothelial would
cause them to accumulate in the capillary beds of many
organs. Subsequent release of oxidants and proteases by
adherent activated neutrophils damages endothelial cells,
and then interstitial and parenchymal cells, with platelets
Fig. 3 Findings in the heart (a, b) and peripheral blood (c, d). a Accumulation of platelets mostly in capillaries. b Marked reduction of ring-like or
tube-like capillary structures, injured capillary endothelial cells have a ragged cytoplasm. c A large scavenger receptor-A positive cell. d A tumor
necrosis factor-α-positive cell. Scal bars: 30 μm. Immunohistochemistry for CD42b (a), CD34 (b), scavenger receptor A (c), and tumor necrosis
factor-α (d)
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also accumulating in capillaries. The consequent tissue in-
jury likely results in multiple organ injury including DAD,
and reperfusion of the cardiac micro-circulation also likely
results in contraction band necrosis. The numbers of large
SRA+ cell at autopsy were different with each other, but
we could not find any correlation between the abundance
of large SRA+ cells and degree of organ damage.
Our histopathologic and cytologic findings in acute ex-
acerbation of IPF and CTD-associated ILD are similar to
those of MODS [15], suggesting that pathophysiologic
mechanisms may be shared to some extent. A variety of
primary insults may provoke MODS [20]. We speculated
that the SRA+ cells and TNF-α+ cells that we detected in
the systemic circulation had differentiated from mono-
cytes stimulated by the primary insult, and there was an
apparent primary insult in each of our MODS cases
[15]. Nonetheless, despite careful examination, we were
unable to find any evidence of extra- pulmonary primary
insults that could have driven the differentiation of SRA
+ and TNF-α+ cells from monocytes in the systemic cir-
culation in our present cases with acute exacerbation.
Scavenger receptor A is the marker of macrophage
[22]. Macrophage differentiate from monocyte by the
stimulation of macrophage colony stimulating factor
(M-CSF) [23]. SRA−monocytes became positive for SRA
after 5 days in culture with M-CSF [24], and differenti-
ated into large macrophages by 10 days [25]. So we be-
lieve that large SRA+ cells in systemic circulation
indicate the presence of lasted high M-CSF level. In our
opinion it will be important to clarify the mechanism
underlying the differentiation and activation of SRA+
cells and TNF-α+ cells in the systemic circulation to illu-
minate the pathogenesis of acute exacerbation of IPF
and CTD-associated ILD.
Conclusion
Acute exacerbation of IPF and CTD-associated ILD appears
to be a systemic disorder that brings about multiple organ
injury, with SRA+ cells and TNF-α+ cells in the systemic
circulation playing central roles. Our findings illuminate
the importance of these cells in the pathophysiology of
acute exacerbation.
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